首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1819886

泌尿生殖藥物市場報告（按適應症、產品和地區）2025-2033

Genitourinary Drugs Market Report by Indication, Product, and Region 2025-2033

出版日期: 2025年09月01日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024 年全球泌尿生殖藥物市場規模達 338 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 398 億美元，2025-2033 年期間的成長率 (CAGR) 為 1.8%。

泌尿生殖系統包括腎臟、輸尿管、膀胱、尿道和生殖器官，在生殖和排出體內廢物方面發揮至關重要的作用。其功能可能因先天畸形、醫源性損傷、癌症、創傷、感染、腎積水和發炎而受損。由於患有這些疾病的人數不斷增加，全球對泌尿生殖藥物的需求也增加。泌尿生殖藥物有助於治療生殖器官、排泄系統和泌尿道疾病。它們也用於治療膀胱痙攣和勃起功能障礙，以及抑制子宮收縮以防止早產。

泌尿生殖藥物市場趨勢：

泌尿生殖器官損傷風險的增加是影響市場成長的主要因素之一。此外，由於泌尿生殖藥物對治療患有慢性腎衰竭和泌尿道感染的兒科患者有效，其全球銷售正在成長。此外，領先的市場參與者正致力於改進製劑技術，以推出有助於治療對傳統化療和荷爾蒙治療藥物產生抗藥性的慢性前列腺癌患者的藥物。此外，一些跨國公司 (MNC) 正在與領先的生物製藥公司合作，推出下一代療法，並鞏固其市場地位。這與後期臨床試驗中在研藥物數量的大幅增加相結合，共同促進了市場成長。此外，研發 (R&D) 計畫資金的增加，以及許多國家政府和非政府機構資助的醫療基礎設施的改善，預計將在未來幾年推動泌尿生殖藥物的需求。

本報告回答的關鍵問題

全球泌尿生殖藥物市場有多大？ 2025-2033年全球泌尿生殖藥物市場的預期成長率是多少？
推動全球泌尿生殖藥物市場發展的關鍵因素有哪些？
COVID-19 對全球泌尿生殖藥物市場有何影響？
根據適應症，全球泌尿生殖藥物市場如何分佈？
根據產品，全球泌尿生殖藥物市場是如何分佈的？
全球泌尿生殖藥物市場的主要區域有哪些？
全球泌尿生殖藥物市場的主要參與者/公司有哪些？
需要更多幫助嗎？

市場結構
關鍵參與者
關鍵參與者簡介
- Allergan plc (AbbVie Inc.)
- Antares Pharma Inc.
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Genentech Inc. (Roche Holding AG)
- GlaxoSmithKline plc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.

簡介目錄圖表

Product Code: SR112025A4727

The global genitourinary drugs market size reached USD 33.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.8 Billion by 2033, exhibiting a growth rate (CAGR) of 1.8% during 2025-2033.

The genitourinary system includes kidneys, ureters, bladder, urethra, and genital organs, which play a vital role in reproduction and getting rid of waste products from the body. Its functioning can be hampered on account of congenital abnormalities, iatrogenic injuries, cancer, trauma, infections, hydronephrosis, and inflammation. Due to the rising number of individuals suffering from these diseases, there is a rise in the demand for genitourinary drugs across the globe. Genitourinary drugs help treat the reproductive organs, excretory system, and urinary tract conditions. They are also used in the treatment of bladder spasms and erectile dysfunction and suppressing uterine contractions to prevent preterm labor.

Genitourinary Drugs Market Trends:

The increasing risk of genitourinary organ damage represents one of the major factors influencing the growth of the market. Moreover, as genitourinary drugs are effective in treating the pediatric population with chronic kidney failure and urinary tract infections, their sales are increasing around the world. Apart from this, the leading market players are focusing on advancing formulation techniques to introduce drugs that help treat chronic prostate cancer patients who have developed resistance to conventional chemotherapeutic and hormone therapy agents. Furthermore, several multinational companies (MNCs) are collaborating with biopharmaceutical leaders to launch next-generation therapeutics and strengthen their position in the market. This, in confluence with a considerable rise in the number of pipeline drugs in late-stage clinical trials, is contributing to the market growth. Besides this, the increasing funding for research and development (R&D) projects, along with improvements in the healthcare infrastructure sponsored by governing and non-governing agencies of numerous countries, is anticipated to drive the demand for genitourinary drugs in the coming years.

Key Market Segmentation:

Breakup by Indication:

Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Renal Cancer
Erectile Dysfunction
Urinary Tract Infections
Urinary Incontinence and Overactive Bladder
Sexually Transmitted Diseases
Interstitial Cystitis
Hematuria
Benign Prostatic Hyperplasia

Breakup by Product:

Urological
Hormonal Therapy
Gynecological
Anti-infectives
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan plc (AbbVie Inc.), Antares Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Genentech Inc. (Roche Holding AG), GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1.How big is the global genitourinary drugs market?
2.What is the expected growth rate of the global genitourinary drugs market during 2025-2033?
3.What are the key factors driving the global genitourinary drugs market?
4.What has been the impact of COVID-19 on the global genitourinary drugs market?
5.What is the breakup of the global genitourinary drugs market based on the indication?
6.What is the breakup of the global genitourinary drugs market based on the product?
7.What are the key regions in the global genitourinary drugs market?
8.Who are the key players/companies in the global genitourinary drugs market?
Need more help?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Genitourinary Drugs Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Indication

6.1 Prostate Cancer
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Ovarian Cancer
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Bladder Cancer
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Cervical Cancer
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Renal Cancer
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
6.6 Erectile Dysfunction
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
6.7 Urinary Tract Infections
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
6.8 Urinary Incontinence and Overactive Bladder
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
6.9 Sexually Transmitted Diseases
- 6.9.1 Market Trends
- 6.9.2 Market Forecast
6.10 Interstitial Cystitis
- 6.10.1 Market Trends
- 6.10.2 Market Forecast
6.11 Hematuria
- 6.11.1 Market Trends
- 6.11.2 Market Forecast
6.12 Benign Prostatic Hyperplasia
- 6.12.1 Market Trends
- 6.12.2 Market Forecast

7 Market Breakup by Product

7.1 Urological
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Hormonal Therapy
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Gynecological
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Anti-infectives
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Allergan plc (AbbVie Inc.)
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 SWOT Analysis
- 13.3.2 Antares Pharma Inc.
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 Financials
- 13.3.3 AstraZeneca plc
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
- 13.3.4 Bayer AG
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 Bristol-Myers Squibb Company
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
  - 13.3.5.4 SWOT Analysis
- 13.3.6 Genentech Inc. (Roche Holding AG)
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 SWOT Analysis
- 13.3.7 GlaxoSmithKline plc
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 Merck & Co. Inc.
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
  - 13.3.8.3 Financials
  - 13.3.8.4 SWOT Analysis
- 13.3.9 Novartis AG
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis
- 13.3.10 Pfizer Inc.
  - 13.3.10.1 Company Overview
  - 13.3.10.2 Product Portfolio
  - 13.3.10.3 Financials
  - 13.3.10.4 SWOT Analysis
- 13.3.11 Teva Pharmaceutical Industries Ltd.
  - 13.3.11.1 Company Overview
  - 13.3.11.2 Product Portfolio
  - 13.3.11.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Genitourinary Drugs Market: Major Drivers and Challenges
Figure 2: Global: Genitourinary Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Genitourinary Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Genitourinary Drugs Market: Breakup by Indication (in %), 2024
Figure 5: Global: Genitourinary Drugs Market: Breakup by Product (in %), 2024
Figure 6: Global: Genitourinary Drugs Market: Breakup by Region (in %), 2024
Figure 7: Global: Genitourinary Drugs (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Genitourinary Drugs (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Genitourinary Drugs (Ovarian Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Genitourinary Drugs (Ovarian Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Genitourinary Drugs (Bladder Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Genitourinary Drugs (Bladder Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Genitourinary Drugs (Cervical Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Genitourinary Drugs (Cervical Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Genitourinary Drugs (Renal Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Genitourinary Drugs (Renal Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Genitourinary Drugs (Erectile Dysfunction) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Genitourinary Drugs (Erectile Dysfunction) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Genitourinary Drugs (Urinary Tract Infections) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Genitourinary Drugs (Urinary Tract Infections) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Genitourinary Drugs (Interstitial Cystitis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Genitourinary Drugs (Interstitial Cystitis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Genitourinary Drugs (Hematuria) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Genitourinary Drugs (Hematuria) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Genitourinary Drugs (Urological) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Genitourinary Drugs (Urological) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Genitourinary Drugs (Hormonal Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Genitourinary Drugs (Hormonal Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Genitourinary Drugs (Gynecological) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Genitourinary Drugs (Gynecological) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Genitourinary Drugs (Anti-infectives) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Genitourinary Drugs (Anti-infectives) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Genitourinary Drugs (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Genitourinary Drugs (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: North America: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: North America: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: United States: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: United States: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Canada: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Canada: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Asia-Pacific: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Asia-Pacific: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: China: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: China: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Japan: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Japan: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: India: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: India: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: South Korea: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: South Korea: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Australia: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Australia: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Indonesia: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Indonesia: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Europe: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Europe: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Germany: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Germany: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: France: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: France: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: United Kingdom: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: United Kingdom: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Italy: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Italy: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Spain: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Spain: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Russia: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Russia: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Others: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Latin America: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Latin America: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Brazil: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Brazil: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Mexico: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Mexico: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Others: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Middle East and Africa: Genitourinary Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Middle East and Africa: Genitourinary Drugs Market: Breakup by Country (in %), 2024
Figure 89: Middle East and Africa: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 90: Global: Genitourinary Drugs Industry: SWOT Analysis
Figure 91: Global: Genitourinary Drugs Industry: Value Chain Analysis
Figure 92: Global: Genitourinary Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Genitourinary Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Genitourinary Drugs Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 3: Global: Genitourinary Drugs Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 4: Global: Genitourinary Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Genitourinary Drugs Market: Competitive Structure
Table 6: Global: Genitourinary Drugs Market: Key Players

02-2729-4219

+886-2-2729-4219